Despite a recent £20 billion boost, the NHS continues to face significant financial challenges. This need to maximise the impact of every penny has contributed to a rise in the demand for specialist input from health economists to directly support commissioning.
Health economists use advanced forecasting and modelling techniques with NHS data sets to explore cause-and-effect relationships, predict future demand and account for uncertainty in business proposals.
Commissioning organisations are increasingly realising that health economics need no longer be confined to academia and has practical applications in the planning process. As economists, we have a role to play in bridging the gap between research and commissioning, deploying our advanced analytic toolkit to support some of the NHS’s most ambitious programmes of work.
The full article, written for Healthcare Finance by Ana Ohde, Senior Health Economist at Arden & GEM, is available here for HFMA members.